HLA-DRB1 and myeloid sarcoma: Our results suggest that HLA DRB1 alleles may have an impact on the clinical manifestation of MS, natural course of the disease and thus provide with some additional information on prognosis and future perspectives to a patient; however, further and large-scale studies are needed.